))
Venture Capital Perspectives: Early Stage Biotech Investing
Manage episode 154229731 series 1116730
Inhoud geleverd door Columbia Tech Ventures and Columbia Technology Ventures. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Columbia Tech Ventures and Columbia Technology Ventures of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Presenting a discussion and Q&A with Doug Cole, managing partner of Flagship Ventures, a life science venture fund with over $1.4 billion under management and a new $574 million fund devoted to early-stage therapeutics, health technologies and sustainability. In an interview with CTV’s Executive Director Orin Herskowitz, Doug discusses Flagship Ventures’ perspective on opportunities and challenges within the venture investment landscape, current trends, past experiences with early-stage investing, its VentureLabs Fellows program, and building a career as a venture capitalist.
…
continue reading
15 afleveringen
Delen
